PERRIGO Co plc (PRGO)
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Perrigo Company plc
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 138.77M shares outstanding
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products.
It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands.
The company also offers contract manufacturing services.
It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies.
The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Leadership
Patrick Lockwood-Taylor
President & CEO; President & Chief Executive Officer
Abbie Lennox
Executive Vice President & Chief Scientific Officer
Eduardo Guarita Bezerra
Executive Vice President & Chief Financial Officer
Charles Atkinson
Executive Vice President, General Counsel & Secretary
Employees
8K+
Country
IE
Sector
Healthcare
Website
perrigo.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Automatic Sell | 607 | $8.3K | Sep 11, 2026 | |
| Director | Option Exercise | 1.3K | -- | Sep 11, 2026 | |
| Director | Option Exercise | 1.3K | -- | Sep 11, 2026 | |
| Director | Automatic Sell | 607 | $8.3K | Sep 11, 2026 | |
| Director | Option Exercise | 1.3K | $17.3K | Sep 11, 2026 | |
| Director | Option Exercise | 1.3K | $17.3K | Sep 11, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 22.7M | 16.4% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jul 2026 | 21.0M | 15.1% | 13G |
Neuberger Berman Group LLC | 10.7M | 7.7% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 9.0M | 6.5% | 13F |
PRICE T ROWE ASSOCIATES INC /MD/ | 8.7M | 6.3% | 13F |
STATE STREET CORP | 8.5M | 6.1% | 13F |
Neuberger Berman Group LLC · also on 13F· may incl. warrants· filed Feb 2026 | 7.5M | 5.4% | 13G |
FULLER & THALER ASSET MANAGEMENT, INC. | 7.5M | 5.4% | 13F |
STATE STREET CORPORATION · also on 13F· may incl. warrants· filed Aug 2025 | 7.3M | 5.3% | 13G |
Dimensional Fund Advisors LP 30-0447847 · also on 13F· may incl. warrants· filed Oct 2024 | 7.0M | 5.0% | 13G |
Insiders
- Parker Geoffrey M.Director
- Alford Bradley ADirector
- Ball DavidEVP & CBDO
- Atkinson CharlesEVP, General Counsel & Sec.
- Winterman Matthew JohnEVP, Supply, Ops, Strategy
- Manzone AlbertInterim President and CEO
- Bezerra Eduardo GuaritaEVP & Chief Financial Officer
- Khoury RobertoEVP and President of CSCI
- Amin Ahmed SalmanDirector
- Willis RobertEVP & CHRO
based on 138.77M shares outstanding
30d Avg
2.47M
60d Avg
2.68M
90d Avg
2.74M